Trends & Business

GOED issued a statement to its members affirming several points, including that the meta-analysis, which showed that omega-3 fatty acid supplementation had no significant associations with CHD death, nonfatal myocardial infarction, any coronary heart disease events, or major vascular events, adds little to the current body of evidence surrounding omega-3s and cardiovascular risk factors.

UL, the global independent safety science company that developed and administers the Supplement OWL, and the Hamacher Resource Group, a category management, business strategy, analytics and brand marketing service provider focusing on retail consumer healthcare, have both announced their willingness-for a nominal per-label fee-to speed the upload process and relieve some of the burden on companies.